Schubert & Co’s Abiomed Inc ABMD Stock Holding History

Schubert & Co’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14	Closed	-$3K	–	1655
2022 Q3	$3K	Buy	14 +3	+27%	+$810	﹤0.01%	710
2022 Q2	$3K	Buy	11 +7	+175%	+$1.89K	﹤0.01%	690
2022 Q1	$1K	Buy	4 +2	+100%	+$616	﹤0.01%	1032
2021 Q4	$1K	Buy	+2	New	+$676	﹤0.01%	971

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Schubert & Co's ABMD Position: Q4 2022 in Review

Schubert & Co sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 14 shares — an estimated $3K sold.

Schubert & Co first reported a position in ABMD in Q4 2021 and held it in 4 quarters. The position peaked at $3K in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Schubert & Co reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Schubert & Co sold 14 Abiomed Inc shares in Q4 2022, an estimated $3K.
Schubert & Co first reported a position in Abiomed Inc in Q4 2021 and held it in 4 quarters.
Schubert & Co's Abiomed Inc position peaked at $3K in Q3 2022.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Schubert & Co's 13F filing for Q4 2022, filed 1 Feb 2023.